Curdia Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 3 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.30 Cr
- Revenue Growth 45.64%
- Profit Growth 116.40%
- Ebitda -23.40%
- Net Worth 224.55%
- Total Assets 7.91%
About Curdia Lifesciences
Curdia Lifesciences Private Limited (CLPL) is a Private Limited Indian Non-Government Company incorporated in India on 20 May 2021 (Three years and eight months 13 days old ). Its registered office is in Ambala, Haryana, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹2.30 Cr.
Simardeep Singh and Jaitsri Arora serve as directors at the Company.
Company Details
-
Location
Ambala, Haryana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U51909HR2021PTC095153
-
Company No.
095153
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
20 May 2021
-
Date of AGM
16 Aug 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
What products or services does Curdia Lifesciences Private Limited offer?
Curdia Lifesciences Private Limited offers a wide range of products and services, including Infusion Syringes & Supplies, Blood Collection Tubes, Plastic & Glass Labware, Laboratory Plasticware, Volumetric Pipette, Medical Laboratory Instruments, Corona Test Kit, Vials and Ampoules.
Who are the key members and board of directors at Curdia Lifesciences?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Simardeep Singh
|
Director | 20-May-2021 | Current |
|
Jaitsri Arora
|
Director | 20-May-2021 | Current |
Financial Performance of Curdia Lifesciences.
Curdia Lifesciences Private Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 45.64% increase. The company also saw a substantial improvement in profitability, with a 116.4% increase in profit. The company's net worth Soared by an impressive increase of 224.55%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Curdia Lifesciences?
Unlock access to Curdia Lifesciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹23.00 M
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 1.80 Cr
- Axis Bank Limited : 0.50 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 05 Feb 2024 | Hdfc Bank Limited | ₹1.80 Cr | Open |
| 29 Sep 2022 | Axis Bank Limited | ₹5.00 M | Open |
How Many Employees Work at Curdia Lifesciences?
Curdia Lifesciences has a workforce of 0 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Curdia Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Curdia Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.